Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restoration of Hypoglycemia Awareness With Metoclopramide
NCT03970720Phase 2Recruiting
- Start
- May 2019
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metoclopramide in Hypoglycemia unawareness (HU) (3 arms). Primary endpoints: Change in Blood Glucagon at 4 weeks, Change in Blood Epinephrine at 4 weeks and 4 more. Started May 2019; status: recruiting.
02
Drugs
metoclopramide
03
Conditions
Hypoglycemia unawareness (HU)
Beyond the preview
Go deeper on NCT03970720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970720.